Amy Ayers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amy Ayers has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Lionel
University of Texas MD Anderson Cancer Center
4 shared publications - Dai Chihara
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3 shared publications - Henderson
University of Texas MD Anderson Cancer Center
3 shared publications - Mark Hamilton
University of Texas MD Anderson Cancer Center
3 shared publications - Michael R. Green
The University of Texas MD Anderson Cancer Center
3 shared publications - Zachary Erin Hunzeker
The University of Texas MD Anderson Cancer Center
3 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Germline Predisposition to Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) after CAR T Cell Therapy for Lymphoma and Myeloma
From the 2026 National Summit on Hematologic Cancers
- 28 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessGermline Predisposition to Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) after CAR T Cell Therapy for Lymphoma and Myeloma
From the 2026 National Summit on Hematologic Cancers
- Open Access
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Epidemiologic Characterization of Risk Factors in Patients with Dual Diagnosis of B-cell and T-cell Lymphomas
From the 2026 National Summit on Hematologic Cancers
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessEpidemiologic Characterization of Risk Factors in Patients with Dual Diagnosis of B-cell and T-cell Lymphomas
From the 2026 National Summit on Hematologic Cancers
- Open Access
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Real World Experience of Anakinra for the Treatment of Corticosteroids-Refractory Neurotoxicity in Large B-cell Lymphoma
From the 2026 National Summit on Hematologic Cancers
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessReal World Experience of Anakinra for the Treatment of Corticosteroids-Refractory Neurotoxicity in Large B-cell Lymphoma
From the 2026 National Summit on Hematologic Cancers
- Open Access
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Survival Outcomes and Treatment Responses in Patients with Dual B-Cell and T-Cell Lymphoma Diagnoses
From the 2026 National Summit on Hematologic Cancers
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessSurvival Outcomes and Treatment Responses in Patients with Dual B-Cell and T-Cell Lymphoma Diagnoses
From the 2026 National Summit on Hematologic Cancers